ArticleHereditas2025
Discovering CRIP1: a novel core gene in osteoarthritis pathogenesis.
Article in Hereditas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOsteoarthritis (OA) is a prevalent chronic degenerative joint disease characterized by complex pathological mechanisms. This study aims to investigate core genes and their associated pathways in OA cartilage.
methodsWe integrated multiple transcriptome datasets, comprising four microarray datasets and two high-throughput datasets. Key pathways related to OA were identified through differential gene analysis, Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, and Gene Set Enrichment Analysis (GSEA). Subsequently, immune infiltration analysis was conducted to explore infiltration characteristics in cartilage tissue, and 113 machine learning algorithms were utilized to identify core genes. The expression of these genes was subsequently verified by qRT-PCR, and an OA diagnostic model was constructed.
resultsGSEA analysis demonstrated significant activation of the ECM-receptor interaction pathway in OA. Utilizing machine learning analysis, we identified APOD, CRIP1, and S100A4 as core genes, with APOD significantly down-regulated and CRIP1 and S100A4 significantly up-regulated. The diagnostic model based on these three genes exhibited robust predictive ability and clinical applicability.
conclusionsThis study highlights the critical role of the ECM-receptor interaction pathway in OA development and identifies APOD, CRIP1, and S100A4 as key regulatory factors. Notably, the potential role of CRIP1 warrants further investigation, providing a novel direction and theoretical foundation for future OA research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.